Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

BGI Genomics Partners with Sanguine to Build Databases of Clinical Trial Patients

publication date: Dec 8, 2017

Shenzhen's BGI Genomics has formed a partnership with California's Sanguine BioSciences, a company that links patients with clinical trials. Using BGI's sequencing machines, Sanguine will develop a database that combines genomic and clinical data to recruit patients for clinical trials of precision medicines. The partnership's first project will build a searchable whole-genome and electronic medical record database of more than 1000 patients with rheumatoid arthritis. More details....

Stock Symbol: (SHZ: 300676)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.